Palo Alto, CA, United States of America

Jiwei Yang

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Recyte Therapeutics, Inc.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jiwei Yang. Retrieved from https://idiyas.com/inventor/jiwei-yang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jiwei Yang - Innovator in Stem Cell Technology

Introduction

Jiwei Yang is a prominent inventor based in Palo Alto, CA. He has made significant contributions to the field of stem cell technology, particularly in the development of perivascular stromal cells. His innovative work has the potential to advance medical research and therapeutic applications.

Latest Patents

Jiwei Yang holds a patent for "Perivascular stromal cells from primate pluripotent stem cells." This invention provides methods, compositions, and kits for making and using pericyte-like cells or perivascular stromal cells derived from primate pluripotent stem cells. This patent highlights his expertise in stem cell research and its applications in regenerative medicine.

Career Highlights

Yang is currently associated with Recyte Therapeutics, Inc., where he continues to explore the potential of stem cell technologies. His work at the company focuses on innovative solutions that leverage the unique properties of stem cells for therapeutic purposes.

Collaborations

Some of his notable coworkers include Midori Greenwood-Goodwin and Dana Larocca. Their collaborative efforts contribute to the advancement of research in the field of stem cell technology.

Conclusion

Jiwei Yang's contributions to stem cell research and his innovative patent demonstrate his commitment to advancing medical science. His work has the potential to impact various therapeutic areas significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…